GLG Pharma’s STAT3 Signaling Inhibitor Selected for NCI’s PREVENT Cancer Preclinical Drug Development Program
Jupiter, Florida July 16, 2013- GLG Pharma, LLC announces scientific and financial resources of the PREVENT Cancer program of the National Cancer Institute of the NIH have been approved to study...
Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy
Insero Health Reports Positive Data on Phase I Trial of Novel Therapy for Drug-resistant Epilepsy —Data Presented at AED Xll Meeting Confirms INS001 Appears Safe and Well Tolerated...
Florida Institute Funds ClearSpec Medical
Boca Raton- Based ClearSpec Medical Receives Florida Institute Funding Seed Funds to Advance Device Development and Commercialization Efforts Gainesville and Boca Raton, FL – July 11, 2013 - The...
CHS Pharma Inc. Welcomes New Board of Director
Jupiter, Florida June 26, 2013- CHS Pharma Inc., an emerging biotechnology company located in Jupiter, Florida, has announced the addition of Robert S. Langer, Sc.D., to its Board of Directors and...
Florida Institute Funds BioFront Technologies
BioFront Technologies Receives Funding Through Florida Institute Seed Capital Accelerator Program Company Based on Technology Developed at Florida State University Gainesville and Boca Raton, FL...